Age: 18+
Healthy Volunteers: Not accepted
Inclusion Criteria:
1. Signed and dated informed consent.
2. Histologically or cytologically confirmed selected locally advanced or metastatic solid tumor.
3. At least 1 measurable lesion according to RECIST v1.1.
4. Progressed after, intolerant to, declined, or not considered a candidate for available standard-of-care (SoC) therapy.
5. Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.
6. Adequate cardiovascular, hematologic, renal, hepatic, and coagulation function.
7. Life expectancy of ≥3 months.
8. Female participants must not be pregnant or breastfeeding. Male participants with female partners of childbearing potential must agree to use effective contraception as specified in the protocol.
Exclusion Criteria
1. Rapidly progressing disease or disease requiring urgent alternative medical intervention.
2. Recent or concurrent malignancy, except certain adequately treated or low-risk malignancies as specified in the protocol.
3. Prior anticancer, investigational, radiation, or immunomodulatory therapy within protocol-specified washout periods, or prior IL-2/IL-15-based therapy.
4. Concurrent participation in another interventional therapeutic clinical trial.
5. Active or clinically significant CNS disease, including symptomatic CNS metastases or leptomeningeal disease, except as specified in the protocol.
6. Clinically significant autoimmune disease, immunodeficiency, requirement for systemic immunosuppressive therapy, or history of severe immune-mediated adverse events.
7. Unresolved clinically significant toxicities from prior anticancer therapy.
8. Clinically significant cardiovascular, thromboembolic, pulmonary, hepatic, or gastrointestinal disease.
9. Active or clinically significant infection except as specified in the protocol.
10. Recent major surgery or trauma, or prior allogeneic hematopoietic stem cell, bone marrow, or solid organ transplantation.
11. Known hypersensitivity or significant allergic reaction to biologics or its components.
12. Recent vaccination, except as permitted by the protocol.
13. Any medical, psychological, social, or other condition that, in the Investigator's opinion, may increase risk, interfere with study participation, or confound interpretation of study results